Brivaracetam and Oxcarbazepine Work Well for Childhood Epilepsy
A study was conducted to compare two medications, brivaracetam and oxcarbazepine, in treating children with self-limited focal epilepsies (SeLFEs).
A study was conducted to compare two medications, brivaracetam and oxcarbazepine, in treating children with self-limited focal epilepsies (SeLFEs).
Researchers studied sexual dysfunction (SD) in people with epilepsy (PWE) to understand how common it is and what factors contribute to it.
This study focused on children with Tuberous Sclerosis Complex (TSC), a genetic condition that can cause various health issues, including tumors in different organs and early-onset epilepsy.
A study was conducted to understand the characteristics and treatment outcomes of epilepsy related to the NPRL3 gene.
This study looked at three newer medications for treating epilepsy: lacosamide (LCM), brivaracetam (BRV), and perampanel (PER).
This study looked at treatments for two serious conditions in children: new onset refractory status epilepticus (a type of severe seizure) and febrile infection-related epilepsy syndrome (a condition that can cause seizures after a fever).
This study looked at how effective a virtual training program was for neurology trainees in Canada learning about epilepsy.
This study looked at the cost-effectiveness of a medication called brivaracetam (BRV) for treating patients in Jordan who have focal-onset seizures that do not respond to other treatments.
Researchers studied how brain activity changes during sleep by looking at a specific type of electrical signal called aperiodic activity.